Web Results

Gilead Sciences, Inc. v. Merck & Co, Inc. et al - Law360

www.law360.com/cases/5362954575127729f8000001/articles

Coverage of federal case Gilead Sciences, Inc. v. Merck & Co, Inc. et al, case number 5:13-cv-04057, from California Northern Court.

granted Merck & Co., Inc.'s motion to dismiss this class-action lawsuit

www.truthinadvertising.org/wp-content/uploads/2014/07/Gisvold-v-Merck-Co-dismissal-.pdf

vs. MERCK & CO., INC. et al.,. Defendants. Pending before the Court in this ... ( collectively “Merck Defendants” or “Merck”) motion to dismiss the First Amended.

Order List - Supreme Court

www.supremecourt.gov/orders/courtorders/051412zor.pdf

May 14, 2012 ... 11-837. ) PUERTO RICO V. UNITED STATES, ET AL. ) 11-876 ... ET AL. 11-1117. SCHNELLER, JAMES D. V. MERCK AND COMPANY, INC.

Risk Factors and Impact of non-Aspergillus mold infections (NAMI ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4740251/

Nov 2, 2015 ... The frequency of certain co-morbid conditions including pulmonary disease, ..... Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co, Inc.; .... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al.

allogeneic hematopoietic cell transplantation for mycosis ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC4221526/

Jul 28, 2014 ... The majority received NST/RIC (n=83), 64% vs. .... Molina et al. in an early report described eight patients undergoing HCT with both MAC and NST/RIC. .... Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, ... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al.

Initiation & completion rates of hepatitis A vaccination among US ...

www.sciencedirect.com/science/article/pii/S0264410X15010324

Nov 27, 2015 ... Declaration of funding: This study was funded by Merck & Co., Inc., Kenilworth, NJ, USA. Declaration of ... [3]; C. Rizzo, V. Alfonsi, R. Bruni, et al.

Merck Frosst Canada Ltd. v. Canada (Health) - SCC Cases (Lexum)

scc-csc.lexum.com/scc-csc/scc-csc/en/item/7988/index.do

Feb 3, 2012 ... v. Minister of Health Respondent. and. BIOTECanada Intervener ..... L.R. 245; Merck Frosst Canada & Co. v. Canada (Minister of Health), 2003 FC 1422 ( CanLII); Rizzo & Rizzo Shoes Ltd. (Re), [1998] 1 ... McDougall, 2008 SCC 53, [ 2008] 3 S.C.R. 41; Société Gamma Inc. v. .... Bastarache, Michel, et al.

Long-term survival outcomes of reduced-intensity allogeneic or ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4703480/

Oct 5, 2015 ... In multivariate models, the main effect (auto-vs. allo-HCT) displayed a time- varying effect .... In contrast, Vose et al. found grade 3 histology to be associated with .... Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co, Inc.; .... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al.

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3947725/

Nov 25, 2013 ... NST/RIC recipients were younger (median age 53 vs. ..... College of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; ... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al.

allogeneic hematopoietic cell transplantation for ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3661721/

Feb 18, 2013 ... However, limited comparisons of autologous vs. allogeneic HCT ... The classification of degree of HLA-match was based on the model proposed by Weisdorf et al. ..... of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; .... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al .

More Info

Merck Drug Patents Asserted Against Gilead Valid, Jury Finds ...

www.law360.com

Mar 22, 2016 ... The case is Gilead Sciences Inc. v. Merck & Co. Inc. et al., case number 5:13-cv- 04057, in the U.S. District Court for the Northern District of ...

Notice of Hearing Session - Judicial Panel on Multidistrict Litigation

www.jpml.uscourts.gov

Apr 14, 2014 ... Southern District of California. DAO v. NATROL, INC., ET AL., C.A. No. 3:13! 02433 .... Fallon Trading Company, Inc., to transfer the following actions to the United States District Court ... RIZZO v. KEURIG GREEN MOUNTAIN, INC., C.A. No. 1:14!11030. - 7 - ..... MERCK & CO., INC., ET AL., C.A. No. 1:14!

Bone Marrow Transplantation - Financial impact of allogeneic ...

www.nature.com

Apr 18, 2016 ... E M Denzen, V Thao, T Hahn, S J Lee, P L McCarthy, J D Rizzo, M Ammi, R Drexler, ... Khera et al. have recently reported a study where they surveyed ..... of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; ...